Omega-3 fatty acids as adjunctive therapeutics: prospective of nanoparticles in its formulation development

Ther Deliv. 2020 Jan;11(1):851-868. doi: 10.4155/tde-2019-0072. Epub 2019 Dec 16.

Abstract

Omega-3 polyunsaturated fatty acids (ω-3-PUFAs) are dietary components that have been extensively recognized for their therapeutic value and have shown diverse therapeutic effects including anti-inflammatory, antiarrhythmic, antithrombotic, immunomodulatory and antineoplastic activities. Most of the ω-3-PUFAs are obtained through diet or supplements because the body does not synthesize them. The high instability of ω-3-PUFAs to oxidative deterioration, lower bioavailability at the target tissues and reduced bioactivity of ω-3-PUFAs is an impediment for achieving their therapeutic potential. The present review provides an overview of potential therapeutic activities of ω-3-PUFAs and different novel technical approaches based on nanotechnology, which have been emphasized to overcome instability problems as well as enhance the bioactivity of ω-3-PUFAs. Future prospects related to this area of research are also provided.

Keywords: drug delivery; microencapsulation; nanoemulsion; nanomedicine; ω-3 polyunsaturated fatty acids.

MeSH terms

  • Diet
  • Dietary Supplements
  • Drug Compounding
  • Fatty Acids, Omega-3*
  • Nanoparticles*
  • Prospective Studies

Substances

  • Fatty Acids, Omega-3